Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA)
- 1 January 1966
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 53 (1), 26-29
- https://doi.org/10.1002/bjs.1800530105
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- ε-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSISBritish Medical Bulletin, 1964
- PATHOLOGICAL FIBRINOLYSISBritish Medical Bulletin, 1964
- Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*JCI Insight, 1964
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. III. DEMONSTRATION OF ABNORMAL CLOT STRUCTURE BY ELECTRON MICROSCOPY*JCI Insight, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*JCI Insight, 1962
- The Use of Epsilon Aminocaproic Acid, a Potent Inhibitor of Fibrinolytic Activity, in the Management of Postoperative HematuriaJournal of Urology, 1961
- Fibrinolysis and Fibrinolytic Activity in ManPhysiological Reviews, 1959
- ETIOLOGY OF FIBRINOPENIA: FIBRINATION DEFIBRINATION*Annals of the New York Academy of Sciences, 1959